Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies

Author(s): Thorvardur R. Halfdanarson, Jonathan R. Strosberg.

Journal Name: Current Clinical Pharmacology

Volume 10 , Issue 4 , 2015

Become EABM
Become Reviewer

Abstract:

Neuroendocrine tumors (NETs) are relatively uncommon. They typically arise in the gastrointestinal tract and lungs, and their incidence seems to be rising. Most patients have advanced disease at the time of diagnosis and many more will relapse after surgery. There is thus a great need for improvements in therapy for advanced neuroendocrine tumors. This article reviews the current therapy for both pancreatic NETs and non-pancreatic gastrointestinal NETs, and discusses recent advances in NET management with an emphasis on targeted therapy.

Keywords: Carcinoid tumors, neuroendocrine tumors, targeted therapy, therapy.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 10
ISSUE: 4
Year: 2015
Page: [305 - 310]
Pages: 6
DOI: 10.2174/1574884710666151020100211
Price: $58

Article Metrics

PDF: 42
HTML: 2
EPUB: 1